Literature DB >> 7263866

Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action.

J G Young.   

Abstract

Published reports of toxic hallucinosis during treatment with methylphenidate are rare. Two cases are described and it is suggested that methylphenidate-induced hallucinosis is more common than has been appreciated. Symptoms may be understood in terms of dose-related effects at pre- and postsynaptic receptors. Two other hypotheses that may clarify underlying mechanisms of action that produce toxic effects relate to (1) noradrenergic facilitation transmission of information in the visual pathway, and (2) interactions among brain monoamine systems.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263866

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  4 in total

Review 1.  Use of Stimulants in Bipolar Disorder.

Authors:  Giulio Perugi; Giulia Vannucchi; Fulvio Bedani; Ettore Favaretto
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 2.  Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors:  Johnny Graham; David Coghill
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  Hallucination and priapism associated with methylphenidate usage: Two case reports.

Authors:  Erman Esnafoglu; Esra Yancar Demir
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

4.  Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system.

Authors:  K K C Man; D Coghill; E W Chan; W C Y Lau; C Hollis; E Liddle; T Banaschewski; S McCarthy; A Neubert; K Sayal; P Ip; I C K Wong
Journal:  Transl Psychiatry       Date:  2016-11-15       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.